Comparing the Relationships of Genetically Proxied PCSK9 Inhibition With Mood Disorders, Cognition, and Dementia Between Men and Women: A Drug‐Target Mendelian Randomization Study
Background PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibitors are important therapeutic options for reducing cardiovascular disease risk; however, questions remain regarding potential differences in the neuropsychiatric impact of long‐term PCSK9 inhibition between men and women. Method...
Main Authors: | Andrew S. Bell, Daniel B. Rosoff, Lucas A. Mavromatis, Jeesun Jung, Josephin Wagner, Falk W. Lohoff |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-11-01
|
Series: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
Subjects: | |
Online Access: | https://www.ahajournals.org/doi/10.1161/JAHA.122.026122 |
Similar Items
-
Assessing the Impact of PCSK9 and HMGCR Inhibition on Liver Function: Drug-Target Mendelian Randomization Analyses in Four AncestriesSummary
by: Daniel B. Rosoff, et al.
Published: (2024-01-01) -
Multi-omic underpinnings of epigenetic aging and human longevity
by: Lucas A. Mavromatis, et al.
Published: (2023-04-01) -
Cholesterol Levels, Hormone Replacement Therapy, and Incident Dementia among Older Adult Women
by: Huei-Ying Chiu, et al.
Published: (2023-10-01) -
Cholesterol efflux capacity of high‐density lipoprotein was not associated with cognitive decline and brain structures in older people with diabetes mellitus
by: Yuanyuan Wu, et al.
Published: (2022-11-01) -
A probability formula derived from serum indicators, age, and comorbidities as an early predictor of dementia in elderly Chinese people
by: Qing Gong, et al.
Published: (2021-08-01)